Skip to main content
TargetHIV
Main menu
  • Home
  • What's New
    • News Feed
    • Blog Roll
    • Stay Informed: RWHAP Email Lists
  • ​About
    • About TargetHIV
    • About the Ryan White HIV/AIDS Program
  • Resources
    • A-Z Topic Index
    • Advanced Search
    • Top Picks
    • Innovation Pipeline
    • Glossary
    • Recursos disponibles en español
  • Events
    • Calendar
    • Webinar Archives
    • National Ryan White Conference
    • CHAC Federal Advisory Committee
  • Assistance
    • Find Ryan White Services
    • Find Technical Assistance & Training
    • Help Desk
    • Forums
    • Log in to My Profile
User menu anonymous
  • Sign in
  • Sign up
Breadcrumb
  1. Home /
  2. Resources

Resources

See A-Z topic list

Topics

  • Medical & Support Services (28)
  • HIV Care Continuum (28)
  • Service Models (6)
  • Ending the HIV Epidemic Initiative (6)
  • Ryan White HIV/AIDS Program & Parts (6)
  • Key Populations (4)
  • Data & Reporting (2)
  • Planning (1)
  • Clinical Quality Management (1)

Type

  • Conference Presentations (23)
  • Documents (9)
  • Webinars (4)
  • Replication Resources (2)
  • Trainings (1)

Source

  • Accelerating Implementation of Long-Acting Injectables (8)
  • Technical Assistance Provider Innovation Network (TAP-in) (5)
  • HRSA HIV/AIDS Bureau (HAB) (2)
  • ACE TA Center (1)
  • EHE Systems Coordination Provider (1)
  • AIDS Education and Training Center Program (1)

Publication Date

  • 2025 (2)
  • 2024 (18)
  • 2023 (3)
  • 2022 (7)
  • 2021 (1)
  • 2020 (2)
Display as
39 items found
How EHE Jurisdictions Can Increase Uptake of Long Acting Injectables for HIV Treatment
Webinars • 08/24/2022
Group Session 8: Long-Acting Injectables
Conference Presentations • 08/20/2024
Group Session 6: Long-Acting Antiretroviral Therapy Among Cis and Transgender Women, and The Design, Implementation, and Expansion of a Long-Acting Injectable Program
Conference Presentations • 08/20/2024
Long-Acting Injectable Therapy for Persons with HIV: A QuizTime Project
Trainings • 01/15/2025
Clinical Monitoring for Real-World Delivery of Long-Acting Injectable Antiretroviral Therapy
Conference Presentations • 08/20/2024
Long-Acting Injectables for HIV Antiretroviral Therapy
Documents • 05/29/2023
Long-acting Injectable HIV Treatment Implementation and Coordination
Conference Presentations • 08/23/2022
Group Session 7: Long-Acting Injectable HIV Treatment
Conference Presentations • 08/20/2024
Educational Approaches about Long-Acting Injectable Treatment for HIV that Enhance Equity: Benefits, Challenges and Strategies
Conference Presentations • 08/20/2024
TAP-in Long-Acting Injectables: The Next Revolution in HIV Treatment
Replication Resources • 12/12/2024
Assessing Perceptions and Preferences around Long-acting Injectables
Conference Presentations • 08/23/2022
Long-Acting ART HIV Treatment Regimens: Key Behavioral Considerations for Stakeholders
Conference Presentations • 08/12/2020
DSHAP Breakout Session: Resources to Address Barriers to Long-Acting Injectable Antiretroviral Therapy
Conference Presentations • 08/20/2024
Pilot and Initial Implementation of Long-Acting Injectable Antiretroviral Therapy at an FQHC: Lessons Learned
Conference Presentations • 08/20/2024
Long-Acting Antiretrovirals in a Ryan-White HIV/AIDS Program in a Health System: Lessons from Adults to Pediatrics
Conference Presentations • 08/20/2024
Micro Learning: Get to know! Long-Acting Injectable PrEP and HIV Treatment
Webinars • 03/24/2023
Long-Acting Injectable Antiretroviral Therapy: Coverage and Cost-Sharing Considerations for RWHAP Clients
Documents • 12/22/2022
HIV Clinic Staff and Community Perspectives on Long-Acting Injectable ART in New York City
Conference Presentations • 08/23/2022
Webinars • 08/24/2022
How EHE Jurisdictions Can Increase Uptake of Long Acting Injectables for HIV Treatment
Conference Presentations • 08/20/2024
Group Session 8: Long-Acting Injectables
Conference Presentations • 08/20/2024
Group Session 6: Long-Acting Antiretroviral Therapy Among Cis and Transgender Women, and The Design, Implementation, and Expansion of a Long-Acting Injectable Program
Trainings • 01/15/2025
Long-Acting Injectable Therapy for Persons with HIV: A QuizTime Project
Conference Presentations • 08/20/2024
Clinical Monitoring for Real-World Delivery of Long-Acting Injectable Antiretroviral Therapy
Documents • 05/29/2023
Long-Acting Injectables for HIV Antiretroviral Therapy
Conference Presentations • 08/23/2022
Long-acting Injectable HIV Treatment Implementation and Coordination
Conference Presentations • 08/20/2024
Group Session 7: Long-Acting Injectable HIV Treatment
Conference Presentations • 08/20/2024
Educational Approaches about Long-Acting Injectable Treatment for HIV that Enhance Equity: Benefits, Challenges and Strategies
Replication Resources • 12/12/2024
TAP-in Long-Acting Injectables: The Next Revolution in HIV Treatment
Conference Presentations • 08/23/2022
Assessing Perceptions and Preferences around Long-acting Injectables
Conference Presentations • 08/12/2020
Long-Acting ART HIV Treatment Regimens: Key Behavioral Considerations for Stakeholders
Conference Presentations • 08/20/2024
DSHAP Breakout Session: Resources to Address Barriers to Long-Acting Injectable Antiretroviral Therapy
Conference Presentations • 08/20/2024
Pilot and Initial Implementation of Long-Acting Injectable Antiretroviral Therapy at an FQHC: Lessons Learned
Conference Presentations • 08/20/2024
Long-Acting Antiretrovirals in a Ryan-White HIV/AIDS Program in a Health System: Lessons from Adults to Pediatrics
Webinars • 03/24/2023
Micro Learning: Get to know! Long-Acting Injectable PrEP and HIV Treatment
Documents • 12/22/2022
Long-Acting Injectable Antiretroviral Therapy: Coverage and Cost-Sharing Considerations for RWHAP Clients
Conference Presentations • 08/23/2022
HIV Clinic Staff and Community Perspectives on Long-Acting Injectable ART in New York City
Webinars • 08/24/2022
How EHE Jurisdictions Can Increase Uptake of Long Acting Injectables for HIV Treatment
Review of the efficacy of LAIs and implementation activities undertaken by agencies.
Conference Presentations • 08/20/2024
Group Session 8: Long-Acting Injectables
Two sessions describing promising strategies for offering LAI in RWHAP clinics. The SPNS ALAI UP project includes a focus on equity in designing and implementing LAI programs.
Conference Presentations • 08/20/2024
Group Session 6: Long-Acting Antiretroviral Therapy Among Cis and Transgender Women, and The Design, Implementation, and Expansion of a Long-Acting Injectable Program
Implementation of long-acting antiretroviral therapy at various sites.
Trainings • 01/15/2025
Long-Acting Injectable Therapy for Persons with HIV: A QuizTime Project
Email-based continuing education course developed by the Southeast AETC in collaboration with the ALAI-UP project.
Conference Presentations • 08/20/2024
Clinical Monitoring for Real-World Delivery of Long-Acting Injectable Antiretroviral Therapy
Long-Acting Injectable Antiretroviral Therapy project's process of developing new clinical performance measures and a methodology to collect and report these data.
Documents • 05/29/2023
Long-Acting Injectables for HIV Antiretroviral Therapy
Guide for EHE jurisdictions on what they can do to enhance implementation of long-acting injectable antiretroviral therapy.
Conference Presentations • 08/23/2022
Long-acting Injectable HIV Treatment Implementation and Coordination

Overview of the policies, procedures, and protocols developed by an ADAP and Part C clinic to establish access to antiretrovirals, including long-acting cabotegravir/rilpivirine.

Conference Presentations • 08/20/2024
Group Session 7: Long-Acting Injectable HIV Treatment
Two RWHAP clinics describe their approaches to providing long-acting injectable antiretroviral therapy.
Conference Presentations • 08/20/2024
Educational Approaches about Long-Acting Injectable Treatment for HIV that Enhance Equity: Benefits, Challenges and Strategies
Strategies for educating all people with HIV about the availability of long-acting injectable (LAI) antiretroviral therapies (ART).
Replication Resources • 12/12/2024
TAP-in Long-Acting Injectables: The Next Revolution in HIV Treatment
This playbook is intended to help EHE jurisdictions consider what they can do to enhance the implementation of long-acting injectables (LAI) for ART.
Conference Presentations • 08/23/2022
Assessing Perceptions and Preferences around Long-acting Injectables
Description of an implementation science project to facilitate equitable access to benefits from LAI ART options.
Conference Presentations • 08/12/2020
Long-Acting ART HIV Treatment Regimens: Key Behavioral Considerations for Stakeholders

This session will focus on key findings and behavioral considerations for long-acting antiretroviral treatment (ART) HIV regimens, given the progress in research, development, and potential approva

Conference Presentations • 08/20/2024
DSHAP Breakout Session: Resources to Address Barriers to Long-Acting Injectable Antiretroviral Therapy
Florida ADAP's pathway to coverage of long-acting Injectable therapy. Barriers addressed include patient adherence, staff training, transportation, costs, and billing.
Conference Presentations • 08/20/2024
Pilot and Initial Implementation of Long-Acting Injectable Antiretroviral Therapy at an FQHC: Lessons Learned
Strategies for implementing a long-acting injectable program.
Conference Presentations • 08/20/2024
Long-Acting Antiretrovirals in a Ryan-White HIV/AIDS Program in a Health System: Lessons from Adults to Pediatrics
Experiences in implementing long-acting cabotegravir plus rilpivirine (LA-CAB/RPV) at a RWHAP-funded clinic within an academic health system and challenges translating into the pediatric clinic.
Webinars • 03/24/2023
Micro Learning: Get to know! Long-Acting Injectable PrEP and HIV Treatment
Review of types of injectable long lasting HIV prevention and treatment medications and their similarities and differences.
Documents • 12/22/2022
Long-Acting Injectable Antiretroviral Therapy: Coverage and Cost-Sharing Considerations for RWHAP Clients
Fact sheet on the different coverage and cost-sharing considerations for LAI ART across public and private payers.
Conference Presentations • 08/23/2022
HIV Clinic Staff and Community Perspectives on Long-Acting Injectable ART in New York City

The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.

  • Load More

Footer

  • Home
  • What's New
    • News Feed
    • Blog Roll
    • Stay Informed: RWHAP Email Lists
  • ​About
    • About TargetHIV
    • About the Ryan White HIV/AIDS Program
  • Resources
    • A-Z Topic Index
    • Advanced Search
    • Top Picks
    • Innovation Pipeline
    • Glossary
    • Recursos disponibles en español
  • Events
    • Calendar
    • Webinar Archives
    • National Ryan White Conference
    • CHAC Federal Advisory Committee
  • Assistance
    • Find Ryan White Services
    • Find Technical Assistance & Training
    • Help Desk
    • Forums
    • Log in to My Profile

Social media links

TargetHIV

Resources and support for HRSA’s Ryan White HIV/AIDS Program

  • Visit us on Facebook (link is external)
  • Visit us on Twitter (link is external)
  • Visit us on YouTube (link is external)
  • Visit us on Instagram (link is external)
  • Visit us on Bluesky (link is external)

Copyright © 2025. TargetHIV is funded by HHS, Health Resources and Services Administration (HRSA), HIV/AIDS Bureau under cooperative agreement #U69HA37645 with the University of California, San Francisco. Its contents are solely the responsibility of the authors. They do not necessarily represent the official views of the HIV/AIDS Bureau.